Racheli Ofir
Chief Executive Officer at Betalin Therapeutics Ltd.
Profile
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd.
Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Racheli Ofir active positions
| Companies | Position | Start |
|---|---|---|
Betalin Therapeutics Ltd.
 Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Chief Executive Officer | 01/12/2022 |
Former positions of Racheli Ofir
| Companies | Position | End |
|---|---|---|
| PLURI INC. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Training of Racheli Ofir
| Technion-Israel Institute of Technology | Doctorate Degree |
| Israel Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Private companies | 1 |
|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Technology Services |
- Stock Market
- Insiders
- Racheli Ofir
